Project Details
Projekt Print View

Identification of epilepsy genes through family studies in the Middle East

Subject Area Molecular and Cellular Neurology and Neuropathology
Term from 2014 to 2019
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 245609332
 
Final Report Year 2019

Final Report Abstract

In summary, the current project performed genetic studies in 119 families affected by epilepsy and neurodevelopmental disorders in Israel and Palestine, including 873 individuals. We identified a monogenic cause in 16/119 families (13,4%), a percentage that was lower than typically seen in large family studies where the diagnostic yield may be up to 30%. Only two genes (SCN1A, KCNQ2) were seen as causative genetic etiologies in more than one family, underlining the genetic heterogeneity in this cohort. Polygenic risk scores failed to translate into our study cohort given the population differences, suggesting that novel strategies are required to assess the contribution of common genetic variants in small pedigrees. Taking together, more than 80% of the familial risk of epilepsy remains unexplained despite state-of-the-art genetic analysis, including analysis of novel genetic etiologies in some individuals. Several novel genetic etiologies including KCNB1, ARHGEF9, and NPRL3 were supported by finding in our current cohort. Our study highlights the role of known monogenic causes in familial epilepsies, emphasizes the need for ongoing gene discovery, and indicates a persisting major gap in explaining the familial risk for epilepsies, even in the presence of genomic information. We aim to extend our studies to include novel methods to analysis complex genetic contributions in families including computational methods for genotype-phenotype correlations, and apply novel genetic analysis techniques including genome sequencing and repeat expansions in the continuation of the current project.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung